Emerging Role of (Endo)Cannabinoids in Migraine
Open Access
- 24 April 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 9, 420
- https://doi.org/10.3389/fphar.2018.00420
Abstract
In this mini-review, we summarize recent discoveries and present new hypotheses on the role of cannabinoids in controlling trigeminal nociceptive system underlying migraine pain. Individual sections of this review cover key aspects of this topic, such as: (i) the current knowledge on the endocannabinoid system (ECS) with emphasis on expression of its components in migraine related structures; (ii) distinguishing peripheral from central site of action of cannabinoids, (iii) proposed mechanisms of migraine pain and control of nociceptive traffic by cannabinoids at the level of meninges and in brainstem, (iv) therapeutic targeting in migraine of monoacylglycerol lipase and fatty acid amide hydrolase, enzymes which control the level of endocannabinoids; (v) dual (possibly opposing) actions of cannabinoids via anti-nociceptive CB1 and CB2 and pro-nociceptive TRPV1 receptors. We explore the cannabinoid-mediated mechanisms in the frame of the Clinical Endocannabinoid Deficiency (CECD) hypothesis, which implies reduced tone of endocannabinoids in migraine patients. We further discuss the control of cortical excitability by cannabinoids via inhibition of cortical spreading depression (CSD) underlying the migraine aura. Finally, we present our view on perspectives of Cannabis-derived (extracted or synthetized marijuana components) or novel endocannabinoid therapeutics in migraine treatment.Funding Information
- Suomalainen Tiedeakatemia (grant 277442)
This publication has 60 references indexed in Scilit:
- On the G-Protein-Coupled Receptor Heteromers and Their Allosteric Receptor-Receptor Interactions in the Central Nervous System: Focus on Their Role in Pain ModulationEvidence-Based Complementary and Alternative Medicine, 2013
- Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in BrainOnline Journal of Public Health Informatics, 2012
- Endocannabinoids limit excessive mast cell maturation and activation in human skinJournal of Allergy and Clinical Immunology, 2012
- Regulation of nausea and vomiting by cannabinoidsBritish Journal of Pharmacology, 2011
- Synthesis and Biological Evaluation of Bivalent Ligands for the Cannabinoid 1 ReceptorJournal of Medicinal Chemistry, 2010
- Cannabinoids as novel anti-inflammatory drugsFuture Medicinal Chemistry, 2009
- Exposure to Marijuana Smoke Impairs Memory Retrieval in MiceThe Journal of pharmacology and experimental therapeutics, 2007
- Cannabinoid (CB1) Receptor Activation Inhibits Trigeminovascular NeuronsThe Journal of pharmacology and experimental therapeutics, 2006
- Adenosine Down-Regulates Giant Depolarizing Potentials in the Developing Rat Hippocampus by Exerting a Negative Control on Glutamatergic InputsJournal of Neurophysiology, 2005
- Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significanceProstaglandins, Leukotrienes & Essential Fatty Acids, 2002